Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement component C5b–9 membrane attack complex is an effector structure assembled from late-stage complement proteins that inserts into target cell membranes. Its main role is immune defense through direct cytolytic activity but it also modulates inflammation via sublytic signaling. Dysregulation contributes significantly to pathology across infectious disease, autoimmunity, cancer biology and transplantation medicine.
Inhibition of C5 cleavage/activation, scavenging of soluble complexes
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component C5b–9 membrane attack complex (MAC).